SEC Form 4 · accession 0001645627-17-000041
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 21, 2017
Accepted (ET)
Apr 24, 2017 · 2:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.058 | A | 20,270,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.058 | A | 20,271,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.058 | A | 20,272,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.058 | A | 20,273,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.058 | A | 20,274,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.058 | A | 20,275,949 | D | |
| Common Stock | Apr 21, 2017 | P | 2,000 | $0.058 | A | 20,277,949 | D | |
| Common Stock | Apr 21, 2017 | P | 2,000 | $0.058 | A | 20,279,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.058 | A | 20,280,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.059 | A | 20,281,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.059 | A | 20,282,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.058 | A | 20,283,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.058 | A | 20,284,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.0645 | A | 20,285,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.0645 | A | 20,286,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.0627 | A | 20,287,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.062 | A | 20,288,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.0618 | A | 20,289,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.0643 | A | 20,290,949 | D | |
| Common Stock | Apr 21, 2017 | P | 2,000 | $0.0643 | A | 20,292,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.0645 | A | 20,293,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.0645 | A | 20,294,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.065 | A | 20,295,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.0646 | A | 20,296,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.069 | A | 20,297,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.0688 | A | 20,298,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.068 | A | 20,299,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.069 | A | 20,300,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.0678 | A | 20,301,949 | D | |
| Common Stock | Apr 21, 2017 | P | 1,000 | $0.0678 | A | 20,302,949 | D |
Table II — derivative securities
No Table II lines on this filing.